Inappropriate dosing of neostigmine for antagonism of neuromuscular blockade has been associated with postoperative pulmonary complications. We evaluated the effects of a quality improvement initiative tailored to optimise the use of neostigmine in antagonising neuromuscular blockade on postoperative pulmonary complications, costs and duration of hospital stay. The quality improvement initiative consisted of: a reduction in available neostigmine aliquot sizes; a cognitive aid; an educational component; and a financial incentive for the intra-operative documentation of train-of-four measurement before administration of neostigmine. We conducted a pre-specified analysis of data obtained in our quality improvement study. Additional analyses were conducted in a propensity-matched cohort. An interrupted time series design was used to discriminate between the intervention and a counterfactual scenario. We analysed 12,025 consecutive surgical cases performed in 2015. Postoperative pulmonary complications occurred in 220 (7.5%) of 2937 cases pre-intervention and 568 (6.3%) of 9088 cases post-intervention. Adjusted regression analyses showed significantly a lower risk of postoperative pulmonary complications (OR 0.73 (95%CI 0.61-0.88); p = 0.001), lower costs (incidence rate ratio 0.95 (95%CI 0.93-0.97); p < 0.001) and shorter duration of hospital stay (incidence rate ratio 0.91 (95%CI 0.87-0.94); p < 0.001) after implementation of the quality improvement initiative. Analyses in a propensity-matched sample (n = 2936 per group) and interrupted time series analysis (n = 27,202 cases) confirmed the findings. Our data show that a local, multifaceted quality improvement initiative can enhance the quality of intra-operative neuromuscular blocking agent utilisation, thereby reducing the incidence of postoperative pulmonary complications.
Introduction
Residual neuromuscular blockade is typically defined as a train-of-four (TOF) ratio (T4/T1) less than 0.9 [1, 2] . It remains a prevalent condition in patients undergoing general anaesthesia, with a reported incidence of 20-50% [3] [4] [5] , and is associated with postoperative pulmonary complications (PPCs) [6] [7] [8] [9] . Residual neuromuscular blockade can be prevented by the use of TOF monitoring to guide the dosing of neuromuscular blocking agents (NMBA) and antagonists [10] . Neostigmine, an acetylcholinesterase inhibitor, is commonly used to antagonise the residual effects of non-depolarising NMBAs at the conclusion of general anaesthesia [11] .
However, neostigmine is not always appropriately dosed, potentially contributing to adverse effects on respiratory function following surgery. A previous study at our hospital showed an independent increase in the risk of PPCs with higher doses of neostigmine [12] , with appropriate doses of neostigmine (< 60 lg.kg À1 after recovery of at least two twitches) associated with better postoperative pulmonary outcomes.
In an effort to reduce the incidence of inappropriate neostigmine use at our institution, a multifaceted quality improvement initiative was implemented. We hypothesised that the quality improvement initiative would decrease the incidence of PPCs.
Methods
Data from all patients who underwent surgery between 1 January 2015 and 31 December 2015 at Massachusetts General Hospital were reviewed. This prospective observational study was undertaken as a quality improvement initiative, and was not subject to formal institutional review board supervision as per our hospital policy. The study was performed in a predefined manner with a statistical analysis plan as per STROBE guidelines [13] .
All adult patients (aged ≥ 18 years) who underwent surgery with tracheal intubation in conjunction with
NMBAs and then had their tracheas extubated immediately after the procedure were considered for inclusion.
Patients who were ASA physical status > 4, and those who had missing information in any of the covariates used in the regression model were not studied. Patient data from these sources were used to form a single de-identified database, as previously reported by our group [14] [15] [16] [17] .
The study population was divided into two groups:
patients who underwent surgery before (pre-QI intervention group) and after (post-QI intervention group) 1 April 2015. This was the initiation date of the quality improvement initiative, which consisted of four components:
1 Modification of the practice environment: 10 mg neostigmine vials that had been stocked in the anaesthesia trolleys were replaced with pre-drawn up syringes containing 3 mg neostigmine;
2 Cognitive aid: a dosing guide for neostigmine was created ( Fig. 1 ) and distributed to all faculty members in both hardcopy and electronic formats, with the guide also attached to each anaesthetic machine [18] ;
3 Education: department-wide grand rounds were organised to discuss relevant studies on residual neuromuscular block and peri-operative NMBA management, together with creation of an electronic repository of these studies; and 4 QI bonus: a financial bonus tied to the documentation of TOF before the administration of neostigmine was instituted.
The change in neostigmine vial size was instituted three months before the department-wide information sessions and other interventions (Fig. 2 ).
The primary outcome was a dichotomised composite measure of the incidence of major PPCs (pneumonia, respiratory failure, pulmonary oedema and/or tracheal re-intubation) within 7 days of surgery. Respiratory outcomes were defined by International Statistical Classification of Diseases (9th or 10th revision), billing diagnostic codes or current procedural terminology codes (Table S1 ) [19] . Secondary outcomes were duration of hospital stay (defined as time from hospital admission to hospital discharge) and total hospital costs (derived from our institution's administrative database).
All statistical analyses were performed retrospectively with pre-specified end-points and statistical methods. Risk factors for residual postoperaƟve paralysis Figure 1 Neuromuscular blocking agent dosing guide (based on Kopman et al. [18] ) used at Massachusetts General Hospital as a cognitive aid in the quality improvement initiative. TOF, train-of-four. included in the regression model [22] . The primary analysis was performed using the complete case method.
To account for potential bias arising from missing data, we repeated the analysis with the entire cohort before exclusion of cases with missing data, using multiple imputations by chained equations [23] . In order to ensure that the observed association between the quality improvement initiative and PPC incidence was not due to an underlying difference between the patient cohorts not captured by the multivariable logistic regression model, a
propensity score-based analysis was performed. The propensity score for a patient's likelihood of undergoing anaesthesia before the quality improvement implementation was calculated based on a priori selected covariates:
sex; age; BMI; type of admission; emergency surgery status; surgical speciality; ASA physical status classification; Charlson Comorbidity Index; SPORC; duration of surgery; vasopressor dose; NMBA dose; duration of hypotension; MAC of inhalation anaesthetics adjusted for age; intra-operative fluid volume; transfused blood units;
and work relative value units. We performed 1:1 nearestnumber matching with a calliper of 0.1 [24] . The primary analysis was repeated within the propensity-matched cohort to examine the robustness of results.
As an exploratory analysis, we conducted interrupted time series analysis. This robust quasi-experimental research design involves constructing a time series of cohort-level rates for a quality improvement focus (e.g. rate of respiratory complications) and testing statistically for a baseline change in the outcome rate around the time period of implementation of the quality improvement initiative. We analysed by segmented regression immediate (level) changes in the outcome rate as well as changes in the trend (slope) [25] . We used the generalised least-square method AR (1) (Fig. 3) . The baseline and intra-operative variables of the study population are presented in Tables 1 and 2 . In the primary regression model, intraoperative fluid volumes and NMBA dose (multiples of the 95% effective dose (ED95)) were categorised in quintiles due to non-linearity of the coefficients.
Two-hundred and twenty (7.5%) out of 2937 patients in the pre-QI intervention group and 568 (6.3%) of 9088 in the post-QI intervention group developed a PPC within seven days of surgery. Patients in the pre-QI intervention group had a significantly higher risk of developing PPCs compared with those in the post-QI intervention group (Table 3) . A significantly shorter duration of hospital stay and decreased costs of hospital care for patients in the post-QI intervention group was also observed ( Table 3 ).
Our findings remained significant when additionally adjusting for PSS for morbidity (odds ratio (OR) for PPCs Tables 1 and 2 . The findings from our primary analyses were confirmed, in that the post-QI intervention group had a lower-risk of PPCs (Table 3) . Imputation of missing data did not affect the results of our study.
In interrupted time series analysis, the weekly mean intra-operative dose of neostigmine decreased over time starting from the beginning of the QI initiative (Fig. 4a) .
Therefore, a stable baseline was stopped and a larger query was conducted by including data from January to (Fig. 4a) . In further interrupted time series analysis, we observed over the course of the study period, a decrease in excessive neostigmine doses (defined as > 60 lg.kg À1 ) (Fig. 4b) , minor change in mean TOF count at the end of the surgery (Fig. 4c) , fewer anaesthetics without recorded TOF counts (Fig. 4d ) and fewer PPCs (Fig. 4e ).
Discussion
In this study, the effect of a multifaceted quality improvement initiative to modify the practice of NMBA reversal in an academic anaesthesia department was analysed. Using prospectively collected intra-and postoperative data, we
showed that the quality improvement interventions were associated with a reduction in the incidence of PPCs.
These findings were confirmed in a propensity score- intervention led to a significant reduction in the incidence of residual neuromuscular block (from 31% to 15%). In a follow-up letter, the authors reported maintenance of these rates for an additional 12 months [28, 29] .
Our current report adds to the literature by demonstrating an association between our interventions and important patient outcomes such as respiratory complications and duration of hospital stay, rather than a 
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